729 results about "Aryl" patented technology

An aqueous ultraviolet-absorbing resin emulsion, and an aqueous resin emulsion composition containing the emulsion is provided, wherein the emulsion is excellent in compatibility with a synthetic resin and light resistance. Also, the emulsion improves stability in blending with an aqueous emulsion of the synthetic resin, and prevents bleed out of the ultraviolet-absorbing resin on the surface of a coating film. Further, the aqueous ultraviolet-absorbing resin emulsion imparts excellent alkali or solvent resistance to a synthetic resin poor in alkali or solvent resistance. More specifically, an aqueous resin emulsion composition comprising (I) an aqueous ultraviolet-absorbing resin emulsion and (II) an other aqueous resin emulsion is provided, wherein the emulsion (I) is obtained by urethanizing (A) a polyol component having an ultraviolet-absorbing group {e.g., 1,1-bis[3-(2H-benzotriazol-2-yl)-4-hydroxy-benzeneethanol]methane}, (B) a polyol if necessary, (C) an alkyl or aryl dialkanolamine compound, and (D) an organic polyisocyanate in (E) an organic solvent, diluting the reaction mixture with (F) an organic solvent having a boiling point lower than 100° C. to give a resin solution, neutralizing the resin solution with (G) a neutralizing agent, and dispersing the resultant in water.

This invention discloses a highly efficient asymmetric synthesis method for aryl propionic acid drug molecules. The method uses racemic aldehydes as substrates and thiamine pyrophosphate-dependent enzymes as biocatalysts. Electrolysis is performed in a diaphragm-free electrolytic cell under conditions of an external redox dielectric and constant current, in a buffer salt solution and nitrogen atmosphere. This method achieves dynamic kinetic oxidation of aldehydes via bioelectrocatalysis, enabling the high-efficiency and high enantioselectivity synthesis of aryl propionic acid drug molecules. The method eliminates the need for redox agents and additives, is simple to operate, operates under mild reaction conditions, and is green and sustainable. This invention applies bioelectrocatalysis to asymmetric synthesis, providing a green and efficient new enzymatic synthetic route for the asymmetric synthesis of aryl propionic acid drug molecules, which has significant application prospects in the pharmaceutical industry.

The application provides a triarylmethane derivative, a pigment dispersion liquid, a preparation method thereof and a photoresist, and relates to the field of photoresists. The structural general formula of the triarylmethane derivative is: wherein X1 is selected from one of long-chain alkyl groups with a length of C1-C12, X2 is selected from hydrogen or an alkyl group, X3 is selected from one of H, an alkyl group and an aromatic group, and Q is selected from one of a carboxyl group, a sulfonic acid group and a phosphoric acid group. The triarylmethane derivative can generate strong van der Waals force and pi-pi conjugation effect with pigment molecules in a colorant by virtue of the large-plane conjugated triarylmethane skeleton, so as to be firmly anchored on the surface of the pigment particles; the strong polar functional groups such as the sulfonic acid group in the molecular structure of the triarylmethane derivative are combined with the alkaline dispersant, the side long-chain alkyl groups fully act on the dispersion medium, and the re-aggregation of the nano pigment particles is effectively prevented through strong steric hindrance and electrostatic stabilization mechanism, so that the problem of poor dispersion stability is solved.

The application discloses an organic electroluminescent material, an organic electroluminescent device and a display device, and the organic electroluminescent material comprises an organic compound shown in formula 1, the organic compound comprises an azole derivative structural unit and a phenanthro (hetero) aryl structural unit, the organic compound can be used as a host material of the organic electroluminescent device, can effectively reduce a driving voltage of the organic electroluminescent device, and can improve the efficiency and the service life of the light-emitting device and the comprehensive performance of the light-emitting device.

Polyoxyalkylene derivatives containing reactive silicon groups, with single or double ends of the polyoxyalkylene chain capped with groups represented by the following structural formula (1), exhibit good curability even when using amine compounds as curing catalysts, resulting in cured products with excellent resistance to yellowing and heat resistance. Wherein, R... 1 and R 2 Each is independently a hydrogen atom, an aliphatic saturated hydrocarbon group having 1 to 10 carbon atoms, or an aryl group having 6 to 10 carbon atoms, R 3 Each group independently represents an aliphatic saturated hydrocarbon group with 1 to 10 carbon atoms or an aryl group with 6 to 10 carbon atoms, where n is an integer from 2 to 12. Lines with wavy lines indicate bonding ends.

The present invention relates to a bismuth-containing catalyst of formula (R1)2-(R2)-(Bi)3+ (I), wherein (R1)2- is a dianion of formula (II*), wherein A is unsubstituted or at least monosubstituted linear C3-30-alkylene, wherein at least two not adjacent CH2 groups of C3-30-alkylene are replaced by a heteroatom independently selected from the group consisting of O, S, 5 NH, N-C1-30-alkyl, N-C6-14-aryl and N-C7-30-aralkyl, wherein alkyl and aryl fragments of N-C1-30-alkyl, N-C6-14-aryl, N-C7-30-aralkyl may at least be monosubstituted by hydroxyl, halogen, -CF3, NH2, -NH-C1-6-alkyl, -NH- phenyl, -N(C1-6-alkyl)2, -N(phenyl)2, -SH, -S-C1-6-alkyl, -S-phenyl, -O-C1-6-alkyl or -O-phenyl, to process for the preparation of the bismuth containing catalyst, to a process for the preparation of a compound, oligomer or polymer comprising at least one urethane group using the bismuth-containing catalyst, to a composition comprising (i) at least one monoalcohol (B1) or polyol (B2), (ii) at least one polyisocyanate (A) and (iii) the bismuth-containing catalyst, to a coating or adhesive layer formed from the composition on a substrate, to a foam formed from the composition, and to the use of the bismuth-containing catalyst in for preparing compounds, oligomers or polymers comprising a urethane group, as esterification and transesterification catalyst and as catalyst for ring-opening polymerizations of lactones and epoxides.

The present invention includes novel compositions and methods for treating comprising a compound with the Formula I:wherein n=0, 1, 2, 3, 4, or 5; X=NH or O or S; Y=phenyl, or a phenyl group substituted with at least one methyl, a phenyl group substituted with at least one nitro, a phenyl group substituted with at least one nitrogen, a phenyl group substituted with at least one boron, aryl, substituted aryl, heteroaryl, four to six membered cycloalkyl, four to six membered heterocycloalkyl; R=H, C(O)R2, SO2R2; R1=H, C(O)R2, SO2R2; R2=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, NH2, NR3R4; R3, R4=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, three to six membered cycloalkyl, and Z=NH, or O, or none, and optionally wherein both X and Z are not both S, and wherein the amount of the compound is selected to either inhibit or activate the immune response.

Catalyst systems comprising a metal-ligand complex having a structure according to Formula (I): Y and Z are independently a monodentate or bidentate ligand selected from the group consisting of (C1−C30)hydrocarbyl, (C1−C30)heterohydrocarbyl, (C6-C30)aryl, (C3-C30)heteroaryl, halogen and –H. R1, R2, R3, and R4 are independently selected from the group consisting of (C1−C30)hydrocarbyl, (C1−C30)heterohydrocarbyl, (C6-C30)aryl, (C3-C30)heteroaryl, −ORC, −Si(RC)3, −Ge(RC)3, halogen, and –H; R5, R6, R7, and R8 are independently selected from the group consisting of (C1−C30)hydrocarbyl, (C1−C30)heterohydrocarbyl, (C6-C30)aryl, (C3-C30)heteroaryl, −ORC, −Si(RC)3, −Ge(RC)3, halogen, and –H; R9 and R10 are independently selected from the group consisting of (C1−C30)hydrocarbyl, (C1−C30)heterohydrocarbyl, (C6-C30)aryl, (C3-C30)heteroaryl, −ORC, −Si(RC)3, −Ge(RC)3, halogen, and –H; and each RC is independently selected from the group consisting of (C1−C30)hydrocarbyl, (C1−C30)heterohydrocarbyl, (C6-C30)aryl, (C3-C30)heteroaryl, and –H.

The application provides a kind of sodium sulfide nine hydrate and activated olefin / acetylene preparation polyether and its method, belong to sulfur-containing polymer technical field.The structural formula of polyether in the application, R 1 And R 2 Independently be substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl;The number of carbon atoms of the alkyl is 1-10, the number of carbon atoms of alkoxy is 1-10, the number of carbon atoms of aryl is 1-30, the number of carbon atoms of heteroaryl is 3-30;Substituted alkyl and substituted alkoxy independently are one or more;N is an integer of 2-4000.The application is used as sulfur source sodium sulfide nine hydrate, under the condition of no metal catalyst, polyether is synthesized by polymerization reaction;Reaction condition is mild, reaction is efficient, economic and environmental protection, meet the current green production concept and can avoid the use of dangerous reagent.

The present application belongs to the technical field of medicine, and relates to a compound containing a heteroaryl ring, a preparation method of the compound, a pharmaceutical composition containing the compound, and use of the compound in treating related diseases (for example, cancer).

The application discloses a method for synthesizing tervalent tetraaryl iron porphyrin from pyrrole, aromatic aldehyde and ferrous salt, which comprises the following steps: adding anhydrous aluminum chloride, aromatic aldehyde, pyrrole and ferrous salt into DMF under stirring, and then heating and refluxing the reaction mixture for 0.5 hours under nitrogen; removing the nitrogen and continuing to heat the reaction mixture for a certain time; stopping the reaction; cooling the reaction mixture; and placing the reaction mixture at 273K overnight; and finally filtering the reaction mixture to obtain the iron porphyrin.

The application belongs to the field of compound synthesis, and discloses a kind of compound containing seven-membered lactam and pyrone skeleton and its construction and application, and the chemical structure is shown in the following, wherein R1 is selected from any one of hydrogen, alkyl, halogen;R2 is selected from any one of alkyl, aryl;R3 is selected from any one of hydrogen, phenyl.The seven-membered lactam and pyrone skeleton has good drug activity, and can be used for preparing antitumor drugs.The application also discloses a construction method of the seven-membered lactam and pyrone skeleton.The construction method of the seven-membered lactam and pyrone skeleton has the advantages that raw materials and catalysts are cheap and easy to obtain, operation is simple and convenient, and the universality of substrates is wide.

The present application belongs to the technical field of condensate, and particularly relates to a non-peptide small molecule condensate and preparation and application thereof. The present application provides a non-peptide small molecule condensate which is prepared by taking a small molecule shown in formula I as a precursor, wherein Y and Z are each independently NH, O or S, R = or X = O or S; R1 and R2 are each independently selected from H, C 3‑20 alkyl, -C 1‑8 alkylene-phenyl, -C 1‑8 alkylene-5-10-membered heteroaryl, -C 1‑8 alkylene-S-C 1‑8 alkyl, -C 1‑8 alkylene-SH, -C 1‑8 alkylene-O-C 1‑8 alkyl or -C 1‑8 alkylene-NH-C 1‑8 alkyl; and R1 and R2 are not H at the same time. The obtained condensate not only has good spontaneous non-classical fluorescence characteristics, but also has the abilities of drug loading and controllable release, and shows excellent resistance to enzymatic hydrolysis and good biocompatibility. Formula I

The present disclosure relates to compounds according to Formula I or a pharmaceutically acceptable salt and / or solvate thereof, wherein X 1 is H, F, or CI; R 1 is H, alkyl, or cycloalkyl; R 2 is H, alkyl, or cycloalkyl; R 3 is H, halo, alkyl, cycloalkyl, heterocyclyl, heteroaryl, or N(R 4 )(R 5 ); and one of R 4 and R 5 is H, alkyl, cycloalkyl, heterocyclyl, or heteroaryl, and the remaining one of R 1 and R 2 is H or alkyl, or R 4 and R 5 together with the nitrogen atom to which they are bound are heterocyclyl or heteroaryl. Furthermore, the present disclosure demonstrates that the compounds of the present disclosure penetrate the central nervous system, thereby allowing for the treatment of central nervous system cancers.

The invention relates to a curable composition comprising (I) at least one silane-modified polymer and / or at least one organopolysiloxane polymer; (II) at least one aminosilane or aminosilane oligomer; (III) at least one guanidine catalyst of Formula (G1) wherein R1 is hydrogen; R2 is selected from the group consisting of optionally substituted alkyls comprising at least 3 carbon atoms, optionally substituted cycloalkyls comprising at least 3 carbon atoms, and optionally substituted C6-C18 aryl; preferably from the group consisting of optionally substituted C3-C8 alkyls, optionally substituted C3-C10 cycloalkyls, and optionally substituted C6-C18 aryl; more preferably R2 is selected from C3-C10 cycloalkyls; R3 is selected from optionally substituted alkyls comprising at least 2 carbon atoms; preferably from optionally substituted C2-C8 alkyls; R4 is selected from optionally substituted alkyls comprising at least 2 carbon atoms; preferably from optionally substituted C2-C8 alkyls; wherein R3 and R4 can be linked so as to form a 3-, 4-, 5-, 6- or 7-membered aliphatic ring, preferably a 5- or 6-membered aliphatic ring, optionally substituted with one or more substituents; and R5 is selected from the group consisting of optionally substituted alkyls comprising at least 3 carbon atoms, optionally substituted cycloalkyls comprising at least 3 carbon atoms, and optionally substituted C6-C18 aryl; preferably from the group consisting of optionally substituted C3-C8 alkyls, optionally substituted C3-C10 cycloalkyls, and optionally substituted C6-C18 aryl; more preferably R5 is selected from C3-C10 cycloalkyls; (IV) optionally, surface treated calcium carbonate; (V) optionally, surface treated silica; and (VI) optionally, at least one plasticizer. The invention also relates to adhesive, sealant, and / or coating materials comprising said composition, the use of at least one guanidine catalyst of Formula (G1) and the use of said composition.

This invention relates to low-odor extreme pressure agents, gear oil additive compositions, gear oil compositions, and methods for their preparation. The extreme pressure agents comprise components having the structure shown in Formula I, where n is a positive integer from 1 to 5; R1 and R2 may be the same or different; R1 and R2 are independently selected from C... 1～12 Alkyl, substituted or unsubstituted C 3～10 cycloalkyl, substituted or unsubstituted C 6～14 aryl or the structure shown in Formula II; in Formula II, R3 is selected from C 1‑4 Alkylene; the substituted C 3～10 Substituents of cycloalkyl groups, substituted C 6～14 The substituents of the aryl group are each independently selected from hydrogen, halogen, and C. 1～5 One or more alkyl groups. The extreme pressure agent and gear oil additive composition of the present invention has a low odor, mainly solving the problem of unbearable odor caused by the addition of sulfurized isobutylene in existing products.

The present application relates to the technical field of pesticide chemistry and medicinal chemistry, and particularly relates to a substituted pyrazole-containing ortho-hydroxy aryl formamide derivative, a preparation method and application thereof. The substituted pyrazole-containing ortho-hydroxy aryl formamide derivative is prepared from a 5-amino pyrazole intermediate (I) and a different substituted ortho-hydroxy aryl formic acid (II) as raw materials through an amide condensation reaction. The substituted pyrazole-containing ortho-hydroxy aryl formamide derivative prepared by the present application has a broad-spectrum inhibitory activity on plant pathogenic fungi, and particularly has excellent inhibitory activity on Valsa mali, Sclerotinia sclerotiorum and Botrytis cinerea, and is expected to be developed into a new type of green fungicide with high efficiency, safety, economy and environmental friendliness.

This application discloses a purino[1,2-a]carbazolin derivative, its preparation method, and its application. Specifically, it discloses a compound having the structure shown in Formula I, or its stereoisomers, solvates, metabolites, pharmaceutically acceptable salts, cocrystals, or prodrugs: ; wherein R1 and R2 are each independently selected from hydrogen, hydroxyl, carboxyl, substituted or unsubstituted C1-C6 alkyl, -CONH-R3, and -COO-R4; wherein R3 is a substituted or unsubstituted C1-C5 alkyl, and the substituent can be any of cyano, halogen, alkylC1-C5 alkoxy, C1-C5 alkylsulfonyl, di(C1-C5 alkyl)amino, nitrogen-containing heterocyclic, aryl, and C1-C5 heteroaryl; R4 is selected from any of substituted or unsubstituted aryl C1-C5 alkyl and nitrogen-containing saturated heterocyclic C1-C5 alkyl. This compound can be used as a TDP1 inhibitor for antitumor therapy.

In the production of crops in agriculture, horticulture, and the like, the occurrence of damage by pests and the like has been still a major issue, and therefore the development of new agricultural / horticultural pesticides has been demanded due to such as the emergence of pests resistant to existing chemicals.　It is discovered that a compound represented by general formula (1) {in the formula, X and Y each represent an oxygen atom or a sulfur atom, Z represents a hydroxyl group or the like, R1 represents an alkoxycarbonyl group or the like, R2 represents a substituted phenyl group or the like, R3 represents a hydrogen atom or the like, and R4 represents a substituted phenyl group or the like} or a salt thereof exhibits a high pesticidal effect on pests and the like in the field of agricultural / horticultural, and the present invention provides an agricultural / horticulturalpesticide using same as active ingredients, and a method for using same.

The present invention provides a novel compound represented by Chemical Formula 1, an optical isomer thereof, or a pharmaceutically acceptable salt thereof. With an excellent inhibitory activity against PIKfyve, the novel compound of the present invention is useful as a therapeutic agent for PIKfyve activity-related cancer disease, inflammatory disease, or lysosomal storage disease.

This application relates to bioabsorbable cationic steroidal antimicrobial (CSA) compounds or salts thereof having a structure of formula I, II or III: formula (I), formula (II) or formula (III), wherein R1-R 18 At least one of them (e.g., R) 18 This includes monoglycerides or diglycerides of fatty acids linked by ester bonds, and R1-R 18 At least one of them (e.g., R3, R7, and R) 12 ) is an amino acid linked to the steroid backbone via an ester bond or an amide bond, wherein: R 18 It has the following structure: -R 19 -(C=O)-O-C-CR 20 -CR 21 , where R 19 The radical is omitted or selected from alkyl, alkenyl, ynyl, and aryl, and R 20 and R 21 Independently selected from hydroxyl, alkylcarboxyl, and aminoalkylcarboxyl groups, provided that R 20 and R 21 At least one of them is an alkyl carboxyl group, R3, R7 and R 12 It has the following structure: R 24 R 23 N-R 22 -(C=O)-X-, where R 22 It is a substituted or unsubstituted alkyl group, X is oxygen or nitrogen, and R is... 23 and R 24 It is independently hydrogen, alkyl, alkenyl, alkynyl, or aryl. (I)(II)(III)

Catalyst systems comprising a metal-ligand complex having a structure according to Formula (I): where M is a metal chosen from scandium or yttrium; X is chosen from silicon or germanium; L is a monodentate or bidentate ligand selected from the group consisting of (C1−C30) hydrocarbyl, (C1−C30) heterohydrocarbyl, (C6−C30)aryl, (C3−C30) heteroaryl, halogen and –H; and Z is a Lewis base. R1, R2, R3, and R4 are independently selected from the group consisting of (C1−C30) hydrocarbyl, (C1−C30) heterohydrocarbyl, (C6−C30)aryl, (C3−C30) heteroaryl, −ORC, −Si(RC)3, −Ge(RC)3, halogen, and –H; R5, R6, R7, and R8 are independently selected from the group consisting of (C1−C30) hydrocarbyl, (C1−C30) heterohydrocarbyl, (C6−C30)aryl, (C3−C30) heteroaryl, −ORC, −Si(RC)3, −Ge(RC)3, halogen, and –H; R9 and R10 are independently selected from the group consisting of (C1−C30)hydrocarbyl, (C1−C30) heterohydrocarbyl, (C6−C30)aryl, (C3−C30) heteroaryl, −ORC, −Si(RC)3, −Ge(RC)3, halogen, and –H; and each RC is independently selected from the group consisting of (C1−C30) hydrocarbyl, (C1−C30) heterohydrocarbyl, (C6−C30)aryl, (C3−C30) heteroaryl, and –H.

Provided are compounds of the structural Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with ALK.

The application discloses a branched polyarylpipeidine film containing a multi-aromatic ring unit and a preparation method and application thereof, and belongs to the technical field of fuel cells and anion exchange membranes for hydrogen production by water electrolysis. The branched polyarylpipeidine main chain is constructed by introducing a multi-aromatic ring branched unit with multiple reaction sites into a conventional linear polyarylpipeidine main chain, so that the packing density of the main chain is reduced, the formation of ion clusters is facilitated, and the membrane conductivity is improved. The branching degree can be controlled by flexibly adjusting the feeding of the multi-aromatic ring branched monomer. The conductivity of the branched polyarylpipeidine film is improved by more than 26% compared with that of the linear film, and the branched film has a lower swelling rate, a higher power density of a hydrogen-oxygen fuel cell and a higher water electrolysis hydrogen production performance.

The application relates to the technical field of organic light-emitting display, and discloses a cyano-substituted aryl ring-connected triazine compound and application thereof. The cyano-substituted aryl ring-connected triazine compound has a structure as shown in formula (I), the compound provided by the application has high bond energy between atoms, good thermal stability, is conducive to solid-state stacking between molecules, is conducive to injection and migration of excitons, can effectively reduce the driving voltage of an organic electroluminescent device when used as an electron transport material, improves the light-emitting efficiency of the organic electroluminescent device, and prolongs the service life of the organic electroluminescent device. Meanwhile, the cyano substitution can adjust the energy level of the compound, the HOMO and LUMO energy levels are deepened, the compound is more matched with adjacent layers, and the device voltage is reduced. The application further provides an organic electroluminescent device and a display device containing the compound of formula (I).

The application discloses a kind of lignin-based aryl formate and diaryl ether compound and synthesis method thereof, belong to the technical field of organic compound synthesis.The method uses lignin β-O-4 model compound as reaction raw material, under the condition of oxidant and alkali, after heating reaction, then join diaryl iodonium under air atmosphere and stir, obtain aryl formate and diaryl ether compound.The synthesis method of the application has the advantages of simple operation, mild reaction condition and high product selectivity, provides a new way for the preparation of aryl formate and diaryl ether compound.

The present application provides a PSMA-targeting ligand compound and chelate thereof and use thereof. The structure of the PSMA-targeting ligand compound is shown in formula I, wherein R1, R2 and R4 are each independently selected from H and optionally substituted C1-C5 linear or branched alkyl; R3 is selected from optionally substituted aryl ring group and optionally substituted aromatic heterocyclic group; X is a sulfur or oxygen atom; Y is selected from a chemical bond and -NH-(CH2)m-, wherein m is an integer selected from 0-18; and Z is a radioactive metal ion chelating group. The pharmacokinetic characteristics of the PSMA-targeting ligand compound are obviously improved, which can be more effectively absorbed by the human body, stably exist in the body, and be taken up and internalized by cancer cells, so that the coupling of the radioactive nuclide can obtain cancer treatment drugs and diagnostic reagents with obviously improved therapeutic effect.